PCI – 7th June 2024
Temax_Krautz
Owen Mumford 12 January 2022, 17:40

Current Edition

Nasal & Pulmonary Drug Development
Cormica Banner Ad – 24.02.2025
Novo Nordisk 20 March 2024, 11:21
Biosynth: Fri 4 October 2024, 10:42

Yesterday, in the presence of numerous guests, the new project partners NEMERA and NOVO NORDISK laid the foundation stone for a new manufacturing Hall

The new building will be mostly dedicated to the production of components for Novo Nordisk’s pen needles.

Marc  HÄMEL,  NEMERA’s  CEO  and  Morten  Keller  CASPERSEN,  NOVO NORDISK’s Corporate Vice Président, laid the foundation stone for the new “Hall 6 manufacturing” building of Nemera La Verpillière yesterday, Thursday 21 mars 2019 at Nemera’s Headquarters and production plant in La Verpillière (France). The ceremony was held in the presence of Patrick MARGIER, La Verpillière Mayor and Vice-President of CAPI (Economic regional pole), Yannick NEUDER, Vice- Président of Auvergne Rhône Alpes region, Jean Pierre GIRARD, first Vice- Président of Nord Isère Chamber of Commerce, Aurélie VERNAY, Damien MICHALET, Counsellors of Isère Department Canton and several other local elected officials and stakeholders.

The construction project for this new production hall is the result of a new collaboration  between  NEMERA  and  NOVO  NORDISK,  a  Danish  health company, the world leader in diabetes care, which has also been operating in France for 60 years.

Marc Haëmel, Nemera’s CEO, is very proud of this achievement: “We are very proud of this new collaboration with Novo Nordisk. We share the same values and the same goal, to improve patients’ lives, providing easy and safe drug delivery devices. We leverage decades of manufacturing and development experience in the parenteral device segment and I hope that this first stone is only the beginning of a long way together”

This new building will be almost entirely dedicated to the production of injected plastic parts, for the Novo Nordisk site in Hjørring, Denmark, which is specialized in the production of needles for insulin injection.

Speaking on the occasion, Morten Keller CASPERSEN, Corporate Vice-Président Novo Nordisk said: “We chose Nemera for many good reasons: impressive manufacturing skills, R&D skills and experience in products development and manufacturing. In general, we got the impression that Nemera thinks and acts like us – being open and honest, transparent in what you do, and operating straight forward processes with out too much complexity.

Even though the project is still in the early stages, Nemera has already shown its execution capabilities: the first batches were received with approx. 6 months lead time! So, it is very good start for what I expect will become a long and fruitful collaboration between our two companies, and I am happy to take part in this very concrete manifestation of our agreement that this ceremony represents.”

This investment of 19.3 million euros will create 150 indirect and 50 direct jobs in the La Verpillière site, including operators, logisticians as well as production, maintenance and quality technicians.

This project is funded by Nemera and Novo Nordisk. The building will meet environmental standards.

The event taking place on the first day of spring, a maple was also planted, to symbolize the commitment of both companies in sustainable development.

Stoelzle Skyscraper: 27th November 2024
Chemspec Europe – 27.02.2025
PHARMAP: Mon 14 October 2024, 10.36
FujiFilm Skyscraper: 26th November 2024
Woolcool 26 March 2024, 16:16
Biopharma group 6 March 2024, 09:40
EyeC 18 March 2024, 13:10
LBBOHLE, Thu 20 April 2023, 17:23
Nipro 14 March 2024, 11:35